Due to their unique dietary fibre composition, in particular β-glucan, the consumption of barley may contribute to a healthy diet and the prevention of colon cancer. The aim of the present study was to analyse chemopreventive effects of barley flakes obtained from a β-glucan-rich barley cultivar. In order to address the impact of heat treatment on potential chemopreventive effects, barley flakes were roasted (160 °C-180 °C, approx. 20 min). The flakes were subjected to in vitro digestion and fermentation. Fermentation supernatants (FS) were analysed for the concentrations of short-chain fatty acids (SCFA) and ammonia. Chemopreventive endpoints (growth inhibition, apoptosis, DNA integrity, gene expression of detoxifying enzymes) were analysed in LT97 colon adenoma cells. Concentrations of SCFA were increased in barley FS (2.5-fold, on average) with a shift of molar ratios towards butyrate production, while ammonia levels were significantly decreased (0.7-fold, on average) compared to the fermentation control. The growth of LT97 cells was significantly reduced by barley FS in a time- and dose-dependent manner, and caspase-3 activity of treated cells was significantly enhanced (up to 6.3-fold, on average). On average, treatment of cells resulted in increased mRNA levels of CAT (2.1-fold), SOD2 (2.2-fold) and GSTP1 (3.9-fold), while expression of GPx1 (0.3-fold) was significantly decreased in some cases. The roasting process did not cause genotoxic effects of barley FS and had no impact on chemopreventive properties. Our results indicate chemopreventive potential of in vitro fermented waxy winter barley, mediated primarily by growth inhibitory and apoptotic effects, which is largely unaffected by roasting.Stimuli-responsive polymer nano-capsules toward a specific signaling molecule show great potential in the fabrication of smart and efficient controlled/targeted drug vehicles. Herein, we design and synthesize a PEG45-b-PVPOP14 diblock copolymer (PEG = poly(ethylene glycol) and PVPOP = poly(4-vinylphenyl 4-oxopentanoate), the subscripts representing the number of repeat units of each block) with levulinate-protected phenol side groups. The PEG45-b-PVPOP14 diblock copolymer could self-assemble to form large compound micelles in aqueous media. Since the core of the large compound micelles formed contains both hydrophilic PEG and hydrophobic PVPOP domains, this kind of micelle is able to load both hydrophobic and hydrophilic species within the core. The ester moiety of levulinate-protected phenol can be selectively cleaved upon incubation with a sulfite, a derivative of SO2 in aqueous media, to give phenol groups.  https://www.selleckchem.com/products/sb297006.html  Thus, the sulfite exhibits the ability to alter the amphiphilicity and further the self-assembled behavior of PEG45-b-PVPOP14. The release of payloads in the core of micelles can be accelerated by triggering of the sulfite. Significantly, the nano-capsule of PEG45-b-PVPOP14 shows specific response to the sulfite (SO2) with slight interference of other bio-species, such as Cys, GSH and Hcy. As far as we are aware, this is the first example of a nano-capsule with sulfite (SO2) specific responsiveness. We envisage that this polymer model could broaden the scope of biological signaling molecule responsive macromolecular systems and provide a new platform to fabricate SO2-responsive biomedicine materials.PURPOSE The purpose of this study was to perform an in vitro evaluation of the protective effects of anticavity agents applied to enamel, by themselves and in combination with ErYAG. MATERIALS AND METHODS In this study 150 extracted third molars were used. Measurements were made using DIAGNOdent, and samples with scores of 0-13 were included in the study. These were divided into 15 groups (n = 20). Use of the agents sodium fluoride (NaF), tricalcium phosphate (Ca3PO4), titanium tetrafluoride (TiF4), Tooth Mousse (CPP-ACP), MI Paste Plus (CPP-ACP), and NovaMin (bioactive glass), individually and then in combination with ErYAG laser, was assessed based on their effects on microhardness values. After treatment, the groups were exposed to a demineralisation solution. Statistical analyses were conducted using SPSS 20.0 package software. RESULTS The highest test result value was observed in the TFL (TiF4/ErYAG laser) group. Statistically significant differences were determined among all the groups (p less then 0.05). When the groups in which the agents were applied alone were compared with those involving combined use of ErYAG laser, combined use provided significantly higher microhardness values, with the exception of the TML group (Tooth Mousse/ErYAG laser) (p less then 0.05). CONCLUSION Within the limits of this study, the combined use of remineralisation agents and ErYAG laser elicited better results than using the agents alone. The most effective remineralisation agent was TiF4/ErYAG laser, which may be considered an alternative method for protecting the enamel against demineralisation.BACKGROUND The number of patients affected by allergies is increasing worldwide. The resulting allergic diseases are leading to significant costs for health care and social systems. Integrated care pathways are needed to enable comprehensive care within the national health systems. The ARIA (Allergic Rhinitis and its Impact on Asthma) initiative develops internationally applicable guidelines for allergic respiratory diseases. METHODS ARIA serves to improve the care of patients with allergies and chronic respiratory diseases. In collaboration with other international initiatives, national associations and patient organizations in the field of allergies and respiratory diseases, real-life integrated care pathways have been developed for a digitally assisted, integrative, individualized treatment of allergic rhinitis (AR) with comorbid asthma. In the present work, these integrated care pathways have been adapted to the German situation and health system. RESULTS The present ICP (integrated care pathway) guideline covers key areas of the care of AR patients with and without asthma. It includes the views of patients and other healthcare providers. DISCUSSION A comprehensive ICP guideline can reflect real-life care better than traditional guideline models. © Dustri-Verlag Dr. K. Feistle.